JENNIFER KUCERA: Open Payments
NPI 1952741084 · SWEENY, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$16,968 in 40 payments from 11 companies in 2025. Trend: 2023 $868 · 2024 $803 · 2025 $16,968
Travel & lodging: $11,753Consulting: $3,440Food & beverage: $1,776
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim International GmbH | 7 | $9,032 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 21 | $6,964 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $167 |
| Novo Nordisk Inc | 4 | $149 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $126 |
| Abbott Laboratories | 1 | $124 |
| Sumitomo Pharma America, Inc. | 1 | $121 |
| Dexcom, Inc. | 1 | $118 |
| Medtronic, Inc. | 1 | $86 |
| AstraZeneca Pharmaceuticals LP | 1 | $50 |
Products named: NEFFY, CARDIOMEMS, APTIOM, DEXCOM G7 GSS (161), VENASEAL, CAPLYTA.
Industry payments across TX — which companies pay providers there.
